Abstract
Only a few animal models of cryoglobulinemic glomerulonephritis have been characterized. Most murine models of mixed cryoglobulinemia occur in the context of autoimmune dysregulation and most resemble diseases such as systemic lupus erythematosus. The thymic stromal lymphopoietin transgenic mouse model of type III mixed cryoglobulinemia currently best replicates the features of cryoglobulinemic membranoproliferative glomerulonephritis (MPGN) as it occurs in humans with mixed cryoglobulinemia, particularly humans infected with hepatitis C virus. This model has been used to test the importance of the inhibitory Fc receptor FcRllb in limiting the severity of disease expression, in demonstrating the deleterious effect of infiltrating monocyte/macrophage populations that is a characteristic feature of this type of glomerulonephritis, and in demonstrating the potential reversibility of MPGN with appropriate therapeutic interventions.
Keywords
- Mixed Cryoglobulinemia
- Glomerular Injury
- Membranoproliferative Glomerulonephritis
- Capillary Basement Membrane
- Thymic Stromal Lymphopoietin
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Kidney Disease: Improving Global Outcomes (KDIGO) (2008) KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis c in chronic kidney disease. Kidney Int Suppl (109):S1–S99
Agnello V (1997) The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 19:111–129
Alpers CE, Smith KD (2008) Cryoglobulinemia and renal disease. Curr Opin Nephrol Hypertens 17:243–249
D’Amico G (1998) Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54:650–671
Hoofnagle JH (2002) Course and outcome of hepatitis C. Hepatology 36:S21–S29
Johnson RJ, Gretch DR, Yamabe H et al (1993) Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465–470
Johnson RJ, Willson R, Yamabe H et al (1994) Renal manifestations of hepatitis C virus infection. Kidney Int 46:1255–1263
Kamar N, Izopet J, Alric L et al (2008) Hepatitis C virus-related kidney disease: an overview. Clin Nephrol 69:149–160
Roccatello D, Fornasieri A, Giachino O et al (2007) Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis 49:69–82
D’Amico G, Fornasieri A (1995) Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus. Am J Kidney Dis 25:361–369
Smith KD, Alpers CE (2005) Pathogenic mechanisms in membranoproliferative glomerulonephritis. Curr Opin Nephrol Hypertens 14:396–403
Barth H, Robinet E, Liang TJ et al (2008) Mouse models for the study of HCV infection and virus-host interactions. J Hepatol 49:134–142
Brass V, Moradpour D, Blum HE (2007) Hepatitis C virus infection: in vivo and in vitro models. J Viral Hepat 14(Suppl 1):64–67
Guidotti LG, Chisari FV (2006) Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 1:23–61
Boonstra A, van der Laan LJ, Vanwolleghem T et al (2009) Experimental models for hepatitis C viral infection. Hepatology 50:1646–1655
Ploss A, Rice CM (2009) Towards a small animal model for hepatitis C. EMBO Rep 10:1220–1227
Kikuchi S, Pastore Y, Fossati-Jimack L et al (2002) A transgenic mouse model of autoimmune glomerulonephritis and necrotizing arteritis associated with cryoglobulinemia. J Immunol 169:4644–4650
Moll S, Schaeren-Wiemers N, Wohlwend A et al (1996) Protease nexin 1 in the murine kidney: glomerular localization and up-regulation in glomerulopathies. Kidney Int 50:1936–1945
Pastore Y, Lajaunias F, Kuroki A et al (2001) An experimental model of cryoglobulin-associated vasculitis in mice. Springer Semin Immunopathol 23:315–329
Guo S, Kowalewska J, Wietecha TA et al (2008) Renin-angiotensin system blockade is renoprotective in immune complex-mediated glomerulonephritis. J Am Soc Nephrol 19:1168–1176
Guo S, Muhlfeld AS, Wietecha TA et al (2009) Deletion of activating Fcgamma receptors does not confer protection in murine cryoglobulinemia-associated membranoproliferative glomerulonephritis. Am J Pathol 175:107–118
Iyoda M, Hudkins KL, Becker-Herman S et al (2009) Imatinib suppresses cryoglobulinemia and secondary membranoproliferative glomerulonephritis. J Am Soc Nephrol 20:68–77
Iyoda M, Hudkins KL, Wietecha TA et al (2007) All-trans-retinoic acid aggravates cryoglobulin-associated membranoproliferative glomerulonephritis in mice. Nephrol Dial Transplant 22:3451–3461
Muhlfeld AS, Segerer S, Hudkins K et al (2003) Deletion of the Fcgamma receptor iib in thymic stromal lymphopoietin transgenic mice aggravates membranoproliferative glomerulonephritis. Am J Pathol 163:1127–1136
Muhlfeld AS, Segerer S, Hudkins K et al (2004) Overexpression of complement inhibitor Crry does not prevent cryoglobulin-associated membranoproliferative glomerulonephritis. Kidney Int 65:1214–1223
Taneda S, Segerer S, Hudkins KL et al (2001) Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am J Pathol 159:2355–2369
Ziegler SF, Artis D (2010) Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 11:289–293
Ziegler SF, Liu YJ (2006) Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol 7:709–714
Turnberg D, Cook HT (2005) Complement and glomerulonephritis: new insights. Curr Opin Nephrol Hypertens 14:223–228
Quigg RJ, He C, Lim A et al (1998) Transgenic mice overexpressing the complement inhibitor Crry as a soluble protein are protected from antibody-induced glomerular injury. J Exp Med 188:1321–1331
Bao L, Haas M, Boackle SA et al (2002) Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice. J Immunol 168:3601–3607
Holers VM, Thurman JM (2004) The alternative pathway of complement in disease: opportunities for therapeutic targeting. Mol Immunol 41:147–152
Thurman JM, Holers VM (2006) The central role of the alternative complement pathway in human disease. J Immunol 176:1305–1310
Wietecha TA, Hudkins KL, Iyoda M et al (2007) Inhibition of complement pathways by combined overexpression of the murine protein Crry and the deletion of factor b in thymic stromal lymphopoietin mice aggravates cryoglobulin-associated membranoproliferative glomerulonephritis. American Society of Nephrology Annual Meeting, San Francisco, CA. J Am Soc Nephrol 18:411A
Wietecha TW, Hudkins KL, Iyoda M et al (2006) Deletion of the murine factor B in thymic stromal lymphopoietin transgenic mice aggravates cryoglobulin-associated membranoproliferative glomerulonephritis. American Society of Nephrology Annual Meeting. San Diego, CA. J Am Soc Nephrol 17:510A
Couser WG (2003) Complement inhibitors and glomerulonephritis: are we there yet? J Am Soc Nephrol 14:815–818
Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8:34–47
Nimmerjahn F, Ravetch JV (2007) Fc-receptors as regulators of immunity. Adv Immunol 96:179–204
Clynes R, Dumitru C, Ravetch JV (1998) Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279:1052–1054
Nakamura A, Yuasa T, Ujike A et al (2000) Fcgamma receptor iib-deficient mice develop goodpasture’s syndrome upon immunization with type iv collagen: a novel murine model for autoimmune glomerular basement membrane disease. J Exp Med 191:899–906
Suzuki Y, Shirato I, Okumura K et al (1998) Distinct contribution of Fc receptors and angiotensin ii-dependent pathways in anti-GBM glomerulonephritis. Kidney Int 54:1166–1174
Park SY, Ueda S, Ohno H et al (1998) Resistance of Fc receptor- deficient mice to fatal glomerulonephritis. J Clin Invest 102:1229–1238
Tarzi RM, Davies KA, Robson MG et al (2002) Nephrotoxic nephritis is mediated by Fcgamma receptors on circulating leukocytes and not intrinsic renal cells. Kidney Int 62:2087–2096
Ellsworth JL, Maurer M, Harder B et al (2008) Targeting immune complex-mediated hypersensitivity with recombinant soluble human FcgammaRIA (CD64A). J Immunol 180:580–589
Woodle ES, Xu D, Zivin RA et al (1999) Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection. Transplantation 68:608–616
Marino M, Ruvo M, De Falco S et al (2000) Prevention of systemic lupus erythematosus in MRL/lpr mice by administration of an immunoglobulin-binding peptide. Nat Biotechnol 18:735–739
Anthony RM, Nimmerjahn F, Ashline DJ et al (2008) Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 320:373–376
Kaveri SV, Lacroix-Desmazes S, Bayry J (2008) The antiinflammatory IgG. N Engl J Med 359:307–309
Kowalewska J, Muhlfeld AS, Hudkins KL et al (2007) Thymic stromal lymphopoietin transgenic mice develop cryoglobulinemia and hepatitis with similarities to human hepatitis c liver disease. Am J Pathol 170:981–989
Banas MC, Banas B, Hudkins KL et al (2008) TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol 19:704–713
Johnson GB, Brunn GJ, Platt JL (2003) Activation of mammalian toll-like receptors by endogenous agonists. Crit Rev Immunol 23:15–44
Taneda S, Hudkins KL, Cui Y et al (2003) Growth factor expression in a murine model of cryoglobulinemia. Kidney Int 63:576–590
Banas MC, Hudkins KL, Wietecha TA et al (2006) Treatment of experimental membranoproliferative glomerulonephritis with a neutralizing anti-TGF-beta1 antibody. American Society of Nephrology Annual Meeting, San Diego, CA. J Am Soc Nephrol 17:179A
Kowalewska J, Hudkins KL, Taneda S et al (2004) Treatment with PDGF r-beta antagonist does not ameliorate cryoglobulin-associated membraphoproliferative glomerulonephritis in thymic stromal lymphopoietin (TSLP) transgenic mice. American Society of Nephrology Annual Meeting, St Louis, MO. J Am Soc Nephrol 15:698A
Segerer S, Hudkins KL, Taneda S et al (2002) Oral interferon-alpha treatment of mice with cryoglobulinemic glomerulonephritis. Am J Kidney Dis 39:876–888
Guo S, Wietecha T, Hudkins K (2008) CD 14 is a mediator of kidney injury in murine cryoglobulinemia-associated membranoproliferative glomerulonephritis (MPGN), American Society of Nephrology Annual Meeting, Philadelphia, 2008
Kobayashi T, Wietecha T, Hudkins KL et al (2010) CD 14 mediates inflammation and kidney injury of MPGN in the TSLP model cryoglobulinemic glomerulonephritis independent of TLR4: American Society of Nephrology Annual Meeting, Denver, 2010
Acknowledgements
The work reported here was supported by grants from the US National Institutes of Health (DK68802) and an unrestricted grant from the Genzyme Renal Innovations Program.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Alpers, C.E., Wietecha, T.A., Hudkins, K.L. (2012). Experimental Models of Mixed Cryoglobulinemia. In: Dammacco, F. (eds) HCV Infection and Cryoglobulinemia. Springer, Milano. https://doi.org/10.1007/978-88-470-1705-4_18
Download citation
DOI: https://doi.org/10.1007/978-88-470-1705-4_18
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1704-7
Online ISBN: 978-88-470-1705-4
eBook Packages: MedicineMedicine (R0)